GSEA KEGG and GO BP results showed that HOXD3 may affect the development of ccRCC cells through primary immunodeficiency, cytokine-cytokine receptor interaction, homologous recombination, et al (Figure 5B). Here, HOXD3 is linked to nonpapillary renal cell carcinoma.